Search

everythinglearnresearchcommunity

for

Search:↓

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Using finasteride with TIP extends time off period for prostate cancer patients.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Male pattern baldness does not cause an increased risk of prostate cancer.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Low-dose bisphenol A increases prostate size in rats by affecting certain enzymes.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

COVID-19 may harm male fertility and damage the reproductive system.